Medeon Biodesign (6499) — Free Cash Flow Generation Index

Latest as of March 2022: 0.32x

Medeon Biodesign (6499) has a Free Cash Flow Generation Index of 0.32x as of March 2022. Free cash flow of NT$19.62 Million represents 0% of operating cash flow (NT$60.74 Million). Explore how much does Medeon Biodesign reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.32x

Free Cash Flow / Operating CF

Free Cash Flow

NT$19.62 Million

TWD

Operating Cash Flow

NT$60.74 Million

TWD

Capital Expenditures

NT$41.12 Million

TWD

Medeon Biodesign Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Medeon Biodesign across 1 annual periods. For the full cash flow conversion analysis, see 6499 cash generation efficiency.

Annual Free Cash Flow Generation for Medeon Biodesign (2018–2018)

Year-by-year Free Cash Flow Generation Index for Medeon Biodesign. Check 6499 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2018	0.83x	NT$267.58 Million	NT$322.05 Million	NT$51.14 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).